Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 12, 2013World's First and Only System with Illumina 3D™ Software and 32 Contacts is Designed to Provide Pain Relief to a Broad Spectrum of Chronic Pain Patients
Boston Scientific Corporation (NYSE: BSX) has received approval by the U.S. Food and Drug Administration and is beginning a limited launch of the...
-
Apr 10, 2013
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2013 on...
-
Mar 21, 2013Results Revealed at CIT 2013
Platinum china trial demonstrates positive outcomes for the BOSTON SCIENTIFIC PROMUS ELEMENT™ STENT Results Revealed at CIT 2013 Beijing (March 21, 2013) – Boston Scientific Corporation...
-
Mar 13, 2013Deadly but Preventable Cancer is a Focus During Colorectal Cancer Awareness Month
NATICK, Mass., March 13, 2013 -- Boston Scientific Corporation (NYSE: BSX) is supporting several public education initiatives throughout the month of March to highlight the prevalence and...
-
Mar 10, 2013Separate Study Demonstrates PROMUS Element Stent has Significantly Less Vessel Straightening than the Xience V® Stent
Boston Scientific Corporation (NYSE: BSX) reported clinical endpoint data from the PLATINUM workhorse clinical trial comparing the safety and...
-
Mar 9, 2013WATCHMAN® Device Continues to Demonstrate Positive Clinical Outcomes for Patients with Atrial Fibrillation
Boston Scientific Corporation (NYSE: BSX) announces the preliminary analysis of the PREVAIL clinical trial data is now available on TCTMD at...
-
Mar 9, 2013
Boston Scientific Corporation (NYSE: BSX) reports preliminary data in the PREVAIL clinical trial met two out of three co-primary endpoints. The...
-
Mar 6, 2013First Presentation of the Preliminary Results of All Three Co-Primary Endpoints to be Revealed During The American College of Cardiology 2013 Annual Scientific Sessions
The Boston Scientific Corporation (NYSE: BSX) PREVAIL clinical trial results will be presented in a Late-Breaking Clinical Trial presentation at the...
-
Mar 6, 2013New Tool Available to Assist in the Treatment of Peripheral Arterial Disease
Boston Scientific Corporation (NYSE: BSX) has begun the launch of its 0.035" and 0.018" Rubicon™ Support Catheter in the United States. The device...
-
Mar 4, 2013
Boston Scientific Corporation (NYSE: BSX) is scheduled to present sponsored research at the 62nd Annual Scientific Session of the American College of...